COGZF:OTC-Cogstate Limited (USD)

COMMON STOCK | Health Information Services |

Last Closing

USD 0.65

Change

0.00 (0.00)%

Market Cap

USD 0.11B

Volume

N/A

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Cogstate Limited, a neuroscience technology company, engages in the creation, validation, and commercialization of digital brain health assessments used in both academic and industry sponsored research. Its cognitive services include project management, data management, scientific consulting, statistical analysis, scales procurement, rater training, and monitoring solutions. The company is involved in the design and provision of quality assurance services in clinical trials, focused on the administration, scoring, and recording of conventional brain health assessments. Its technology and associated services are used to quantify the effect of diseases and drugs, and devices or other interventions on human subjects participating in clinical trials primarily conducted by pharmaceutical and biotechnology companies. In addition, the company provides Cognigram, a computerized test to aid healthcare professionals for cognitive decline. Cogstate Limited was incorporated in 1999 and is based in Melbourne, Australia.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-26 )

Largest Industry Peers for Health Information Services

Symbol Name Price(Change) Market Cap
PMCUF Pro Medicus Limited

-3.81 (-3.20%)

USD 12.25B
MTHRY M3 Inc

-0.02 (-0.29%)

USD 6.94B
SMSZF SMS Co. Ltd

N/A

USD 1.52B
PANHF Ping An Healthcare and Technol..

N/A

USD 1.43B
SMSSY SMS Co., Ltd.

-0.18 (-2.24%)

USD 1.33B
CRWRF Craneware plc

N/A

USD 1.07B
SUSRF Surgical Science Sweden AB (pu..

N/A

USD 0.61B
SFSVF Software Service, Inc.

N/A

USD 0.50B
VHIBF Vitalhub Corp

N/A

USD 0.34B
KSIOF kneat.com inc.

+0.01 (+0.29%)

USD 0.31B

ETFs Containing COGZF

N/A

Market Performance

  Market Performance vs. Industry/Classification (Health Information Services) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -36.27% 46% F 23% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -36.27% 44% F 23% F
Trailing 12 Months  
Capital Gain -32.99% 54% F 30% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -32.99% 53% F 30% F
Trailing 5 Years  
Capital Gain 261.11% 88% B+ 94% A
Dividend Return N/A N/A N/A N/A N/A
Total Return 261.11% 88% B+ 93% A
Average Annual (5 Year Horizon)  
Capital Gain 61.26% 79% B- 79% B-
Dividend Return 61.26% 79% B- 78% C+
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 105.73% 43% F 33% F
Risk Adjusted Return 57.94% 95% A 89% A-
Market Capitalization 0.11B 85% B 59% D-

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Superior return on assets

The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior return on equity

The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

What to not like:
Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector